Lupin - Global Pharmaceutical Leader | Innovations in Healthcare

February 4, 2026

Lupin Launches Topiramate
Extended-Release Capsules in
the United
States

February 2, 2026

Lupin and TB Alliance Join
Forces to Advance Telacebec for
the Treatment of Tuberculosis and
Other Mycobacterial
Diseases

February 2, 2026

Lupin Launches
Dasatinib Tablets
in the
United
States

January 23, 2026

Lupin Receives Highest ESG
Rating from CDP for
Climate Change and Water
Security

January 21, 2026

Lupin and Galenicum Sign
License and Supply Agreement
for Semaglutide in 23
Countries

December 29, 2025

Lupin Signs Exclusive Licensing
Agreement with Gan &
Lee Pharmaceuticals for novel
GLP-1 receptor
agonist

MediaContacts

Rajalakshmi Azariah

Vice President and Global Head – Corporate Communications

rajalakshmiazariah@lupin.com